Skip to main content
Caplight Logo









Cellens Inc.

Cellens Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://cellensinc.com/

Last Round

Seed

Dec 23, 2025

Total Funding Raised

$6.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Cellens Inc. is a healthcare company that develops a cell surface scanning platform designed for noninvasive detection of bladder cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

cancer diagnosticsbladder cancer testnon-invasive diagnosticsliquid biopsybladder cancer surveillanceAI diagnosticsmechanobiologyatomic force microscopyAFMcancer recurrence monitoringurology diagnosticsbiophysical biomarkersrule-out testdiagnostics-as-a-serviceCLIA-certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellens Inc. Comparables

Compare Cellens Inc. with similar companies based on industry and business-model similarity.

Cellens Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VitaDX
81%
Nucleix
79%
Nonagen Bioscience Corporation
79%

Cellens Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 23, 2025

Key People

Founding team and executive leadership

Jean Phuong Pham

Co-Founder & CEO

Founding Team

Cellens Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 78% MoM.

  • Jan 21, 2026

    Grew 36% QoQ from 11 to 15 employees.

Cellens Inc. Filings

Explore SEC and related filing metadata, where available.

Cellens Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellens Inc.'s valuation, stock price, and market status.

Is Cellens Inc. a public or private company?

Cellens Inc. is a private company.

What is the current stock price of Cellens Inc.?

Cellens Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Cellens Inc. worth (valuation)?

Valuation information for Cellens Inc. is not publicly available.

Can I buy Cellens Inc. stock?

Cellens Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellens Inc.'s last funding round?

Cellens Inc.'s most recent funding round was Seed on December 23, 2025.

Who are the main investors in Cellens Inc.?

Key investors in Cellens Inc. include SOSV.

Will Cellens Inc. IPO soon?

No public IPO plans have been announced for Cellens Inc..

How can I track Cellens Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellens Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range16
Year Founded2020
Last FundingDec 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?